Eugène Baltes

587 total citations
8 papers, 440 citations indexed

About

Eugène Baltes is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Eugène Baltes has authored 8 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pharmacology and 2 papers in Molecular Biology. Recurrent topics in Eugène Baltes's work include Drug Transport and Resistance Mechanisms (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Eugène Baltes is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Eugène Baltes collaborates with scholars based in Belgium, United States and Italy. Eugène Baltes's co-authors include M. Strolin Benedetti, Barry E. Gidal, Emilio Perucca, René Coupez, Rhys Whomsley, J.G. Gobert, Christian Otoul, Catherine Arendt, Nigel McCracken and Hilde Giezek and has published in prestigious journals such as Epilepsy Research, European Journal of Clinical Pharmacology and Expert Opinion on Drug Metabolism & Toxicology.

In The Last Decade

Eugène Baltes

8 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugène Baltes Belgium 7 150 135 91 89 88 8 440
J. Roba Belgium 12 94 0.6× 92 0.7× 46 0.5× 10 0.1× 125 1.4× 44 442
A.P. Intoccia United States 8 46 0.3× 21 0.2× 35 0.4× 9 0.1× 96 1.1× 14 438
Chiyuki Yamato Japan 14 26 0.2× 17 0.1× 57 0.6× 13 0.1× 157 1.8× 34 522
David J. Spalding United Kingdom 13 58 0.4× 26 0.2× 72 0.8× 4 0.0× 154 1.8× 21 579
Gustaf Plym Forshell Sweden 11 40 0.3× 72 0.5× 12 0.1× 5 0.1× 117 1.3× 21 432
Roeline Jochemsen France 9 59 0.4× 16 0.1× 9 0.1× 5 0.1× 99 1.1× 12 496
Julie A Gratton United Kingdom 8 23 0.2× 25 0.2× 42 0.5× 3 0.0× 96 1.1× 10 486
P. P. K. Ho United States 11 15 0.1× 6 0.0× 135 1.5× 20 0.2× 134 1.5× 20 531
Marcus F. Brackeen United States 12 10 0.1× 18 0.1× 78 0.9× 8 0.1× 253 2.9× 16 651
G. H. Phillipps Germany 11 25 0.2× 7 0.1× 149 1.6× 52 0.6× 208 2.4× 32 588

Countries citing papers authored by Eugène Baltes

Since Specialization
Citations

This map shows the geographic impact of Eugène Baltes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugène Baltes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugène Baltes more than expected).

Fields of papers citing papers by Eugène Baltes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugène Baltes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugène Baltes. The network helps show where Eugène Baltes may publish in the future.

Co-authorship network of co-authors of Eugène Baltes

This figure shows the co-authorship network connecting the top 25 collaborators of Eugène Baltes. A scholar is included among the top collaborators of Eugène Baltes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugène Baltes. Eugène Baltes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Benedetti, M. Strolin, Rhys Whomsley, & Eugène Baltes. (2006). Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics. Expert Opinion on Drug Metabolism & Toxicology. 2(6). 895–921. 64 indexed citations
2.
Benedetti, M. Strolin, Michel Gillard, & Eugène Baltes. (2006). Estimation of Receptor Occupancy. Allergy & Clinical Immunology International - Journal of the World Allergy Organization. 18(3). 131–133. 2 indexed citations
3.
Gidal, Barry E., Eugène Baltes, Christian Otoul, & Emilio Perucca. (2005). Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: A pooled analysis of data from randomized clinical trials. Epilepsy Research. 64(1-2). 1–11. 56 indexed citations
4.
Perucca, Emilio, Barry E. Gidal, & Eugène Baltes. (2003). Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials. Epilepsy Research. 53(1-2). 47–56. 88 indexed citations
5.
Brée, Françoise, et al.. (2002). Blood distribution of levocetirizine, a new non‐sedating histamine H1‐receptor antagonist, in humans. Fundamental and Clinical Pharmacology. 16(6). 471–478. 17 indexed citations
6.
Baltes, Eugène, et al.. (2001). Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundamental and Clinical Pharmacology. 15(4). 269–277. 63 indexed citations
7.
Benedetti, M. Strolin, et al.. (2001). Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers. European Journal of Clinical Pharmacology. 57(8). 571–582. 85 indexed citations
8.
Baltes, Eugène, et al.. (1988). Gas chromatographic method for the determination of cetirizine in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 430(1). 149–155. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026